Shunan Qi

9PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.

Jing Yang, Qiu-Zi Zhong, Li-Ting Qian

|Mar 20, 2024
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma.

Lin-Rui Gao, Xin Li, Xinyue Wang

|Mar 25, 2023
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancer.

Guang-Yi Sun, Jing Zhang, Bing-Zhi Wang

|Nov 18, 2022
Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study.

Shunan Qi, Xin Liu, Ariela Noy

|Nov 14, 2022
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy.

Yang-Mei Zhou, Xin Liu, Yong Yang

|Aug 03, 2021
Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.

Yong Yang, Ying Wang, Xin Liu

Pageof 2

Frequent Collaborators

7 joint publications

Ye-Xiong Li

3 joint publications

Chen Hu

2 joint publications

Li-Ming Xu

1 joint publications

Guang-Yi Sun